Phase 3 Ovarian Cancer Trial, Decitabine Priming Added
Summary
ClinicalTrials.gov record for NCT02159820: a Phase 3 interventional study evaluating decitabine priming in ovarian cancer treatment. The trial is registered as an active study with an overall status of 'Recruiting'. No regulatory compliance deadlines, enforcement actions, or substantive rule changes are associated with this database entry.
About this source
GovPing monitors ClinicalTrials.gov - Phase 3 Oncology Trials for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 3 changes logged to date.
What changed
This entry documents the registration of a Phase 3 clinical trial (NCT02159820) investigating decitabine priming in ovarian cancer on ClinicalTrials.gov, the NIH-maintained clinical study database. The listing provides basic trial metadata including study title, condition (ovarian cancer), intervention (decitabine), and recruitment status. No regulatory obligations, compliance deadlines, or enforcement actions are created by this database entry.
Affected parties including clinical investigators, pharmaceutical sponsors, and institutional review boards should note this trial represents active Phase 3 oncology research. This registration does not constitute FDA approval or endorsement of the investigated therapy.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Show glossary
Mentioned entities
Related changes
Get daily alerts for ClinicalTrials.gov - Phase 3 Oncology Trials
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov - Phase 3 Oncology Trials publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.